ABBVIE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.7 USD | -0.57% |
|
-3.62% | +4.36% |
| Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
| Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBVIE INC. | Other Pharmaceuticals | -0.57% | -3.62% | +4.36% | +5.21% | +104.99% | 288B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
- Comparison Chart
